Physician

Carl R Gray, M.D.

According to 2025 Medicare claims, Carl Gray, M.D. (NPI: 1598873382) practices hematology in the Ogden, UT market, with the plurality of this provider's patient population coming from Weber, UT. This provider's primary affiliated billing organization is OGDEN CLINIC SPECIALTY SERVICES LLC (NPI: 1114203668; TIN: 85-3002963) and primary practice location at 84405-7194. Gray is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Aledade 155 National MSSP (ACO ID: A5358), participating under the MSSP model.

Gray's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 512,033 HCPCS/CPT codes, and received $9,682,167 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 1,851 prescription claims across 306 beneficiaries totaling $4,747,308 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 55 claims. Open Payments data shows 241 records totaling $661,279. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $5,029,692 and ending at $9,682,167. Concurrently, Part D prescription costs have risen steadily, from $1,313,633 to $4,747,308. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $29,969 to $4,417.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	816	695,913	$5,029,692
2016	833	725,972	$6,648,915
2017	892	607,421	$6,751,995
2018	1,002	932,312	$8,599,584
2019	913	940,654	$10,670,666
2020	914	905,173	$10,514,237
2021	1,154	1,030,391	$12,685,199
2022	863	508,085	$8,167,588
2023	398	424,418	$7,529,815
2024	373	512,033	$9,682,167

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	281	2,077	$1,313,633
2016	289	2,192	$1,909,139
2017	310	2,069	$2,381,162
2018	312	1,934	$3,833,557
2019	246	1,447	$2,974,325
2020	245	1,126	$2,314,600
2021	227	1,140	$3,051,374
2022	264	1,391	$3,344,459
2023	263	1,337	$2,720,332
2024	306	1,851	$4,747,308

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	73	674	$57,504
2016	11	381	$20,292
2017	N/R	217	$44,183
2018	N/R	185	$10,624
2019	N/R	68	$2,975
2020	N/R	171	$9,059
2021	11	120	$8,313
2022	N/R	76	$4,161
2023	N/R	90	$6,829
2024	N/R	55	$3,134

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	206	780	$134
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	158	293	$12
80053	Blood test, comprehensive group of blood chemicals	261	1,179	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	271	1,469	$8
36415	Insertion of needle into vein for collection of blood sample	156	463	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	104	2,849	$1,085,171
Cabometyx	Cabozantinib S-Malate	29	870	$736,199
Revlimid	Lenalidomide	36	980	$601,947
Erleada	Apalutamide	23	750	$354,542
Kisqali	Ribociclib Succinate	19	532	$293,231

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	42	$2,930
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$204

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	154	$3,022	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	87	$658,257	Regeneron Pharmaceuticals, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl R. Gray, M.D.?

Tedicare shows public-source Medicare data for Carl R. Gray, M.D. (NPI 1598873382), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl R. Gray, M.D. have ACO affiliation data?

Carl R. Gray, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and Aledade 155 National MSSP (MSSP, ACO ID A5358).

What billing organization is linked to Carl R. Gray, M.D.?

Carl R. Gray, M.D. is linked to OGDEN CLINIC SPECIALTY SERVICES LLC (billing NPI 1114203668) in the available physician profile data.

Does Carl R. Gray, M.D. have Open Payments data?

Carl R. Gray, M.D. has 241 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.